Published in PLoS One on February 28, 2014
The instructive role of innate immunity in the acquired immune response. Science (1996) 5.50
TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med (2007) 5.41
Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest (1998) 4.92
Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci (1995) 3.78
Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol (2000) 3.61
Neuronal death in glaucoma. Prog Retin Eye Res (1999) 3.46
Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes (2006) 3.31
Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res (2004) 3.08
See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol (2006) 2.62
Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res (2006) 2.49
The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res (2000) 2.44
Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci (1991) 2.37
A look at autoimmunity and inflammation in the eye. J Clin Invest (2010) 2.30
The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res (2011) 2.26
Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res (1995) 2.21
The genetics of primary open-angle glaucoma: a review. Exp Eye Res (2008) 2.14
Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res (2001) 2.13
TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol (1997) 2.11
Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia (2000) 1.87
Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci (2000) 1.84
Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci (2002) 1.82
Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol (2009) 1.56
The immune system and glaucoma. Curr Opin Ophthalmol (2004) 1.51
Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp Eye Res (2010) 1.44
Optic nerve head extracellular matrix in primary optic atrophy and experimental glaucoma. Arch Ophthalmol (1990) 1.34
The optic nerve head in glaucomatous optic neuropathy. Arch Ophthalmol (1997) 1.26
Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes. Mol Vis (2012) 1.26
Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J Immunol (2010) 1.24
Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs. Br J Ophthalmol (2006) 1.23
MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte. Cancer Res (1999) 1.20
Immunoregulation of retinal ganglion cell fate in glaucoma. Exp Eye Res (2009) 1.20
Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod. Clin Exp Dermatol (2007) 1.19
Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina. Invest Ophthalmol Vis Sci (2011) 1.17
Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats. Neuropathology (2002) 1.15
Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia (2010) 1.14
Th17 cells and activated dendritic cells are increased in vitiligo lesions. PLoS One (2011) 1.14
Amplification of a reactive oxygen species signal in axotomized retinal ganglion cells. Antioxid Redox Signal (2003) 1.11
Efficacy of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in the rodent retina. Invest Ophthalmol Vis Sci (2008) 1.09
Opioid receptor-activation: retina protected from ischemic injury. Invest Ophthalmol Vis Sci (2009) 1.09
A quantitative increase in regulatory T cells controls development of vitiligo. J Invest Dermatol (2013) 1.05
Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor. Curr Eye Res (2007) 1.03
Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat. Diabetologia (1992) 0.97
T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma. Am J Ophthalmol (2001) 0.97
Autoimmunity and glaucoma. J Glaucoma (2008) 0.97
Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J Immunol (1997) 0.95
A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice. J Immunol (2012) 0.94
Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model. Invest Ophthalmol Vis Sci (2012) 0.93
Development of neovascular glaucoma in the course of interferon alfa therapy for hepatitis type C. Br J Ophthalmol (1994) 0.90
Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-α in the retina. Invest Ophthalmol Vis Sci (2011) 0.90
Development of glaucoma in the course of interferon alpha therapy for chronic hepatitis B. Yonsei Med J (2001) 0.87
AAV-mediated tyrosinase gene transfer restores melanogenesis and retinal function in a model of oculo-cutaneous albinism type I (OCA1). Mol Ther (2009) 0.87
Expression of interferon-gamma in the lens exacerbates anterior uveitis and induces retinal degenerative changes in transgenic Lewis rats. Clin Immunol (1999) 0.86
Effect of IL-1beta on survival and energy metabolism of R28 and RGC-5 retinal neurons. Invest Ophthalmol Vis Sci (2008) 0.85
The case for autoimmunity in glaucoma. Exp Eye Res (2010) 0.85
Neuroprotective effects of cilostazol on retinal ganglion cell damage in diabetic rats. J Pharmacol Exp Ther (2013) 0.84
Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model. Invest Ophthalmol Vis Sci (2013) 0.83
Combined central retinal vein and central retinal artery occlusions and neovascular glaucoma associated with interferon treatment. Eur J Ophthalmol (2012) 0.80